Mannkind (MNKD) Profit After Tax (2010 - 2026)
Mannkind's (MNKD) quarterly Profit After Tax came in at -$16.6 million in Q1 2026, down 226.3% year-on-year from $13.2 million in Q1 2025, and down 4.21% on a QoQ basis from -$15.9 million in Q4 2025.
Mannkind (MNKD) Profit After Tax (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Profit After Tax data on file, last reported at -$16.6 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 226.3% year-over-year to -$16.6 million in Q1 2026; TTM through Mar 2026 was -$23.9 million, a 179.41% decrease from a year earlier, with the FY2025 full-year figure at $5.9 million, down 78.75% from the prior year.
- Profit After Tax for Q1 2026 stood at -$16.6 million, down from -$15.9 million in the prior quarter.
- Over the last five years, Profit After Tax for MNKD reached as high as $13.2 million in Q1 2025 and fell as low as -$29.0 million in Q2 2022.
- Historically, Profit After Tax has averaged -$4.9 million across 5 years, with a median of -$2.0 million in 2024.
- Across the five-year window, Profit After Tax soared 571.12% in 2024 and slumped 314.87% in 2025, its largest moves.
- Year by year, Profit After Tax stood at -$17.9 million in 2022, then soared by 107.81% to $1.4 million in 2023, then soared by 429.76% to $7.4 million in 2024, then plunged by 314.87% to -$15.9 million in 2025, then fell by 4.21% to -$16.6 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$16.6 million in Q1 2026, -$15.9 million in Q4 2025, and $8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | -16.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.62 Mn |
| Dec 31, 2025 | -15.95 Mn |
| Sep 30, 2025 | 7.99 Mn |
| Jun 30, 2025 | 668,000.00 |
| Mar 31, 2025 | 13.16 Mn |
| Dec 31, 2024 | 7.42 Mn |
| Sep 30, 2024 | 11.55 Mn |
| Jun 30, 2024 | -2.01 Mn |
| Mar 31, 2024 | 10.63 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | -5.27 Mn |
| Mar 31, 2023 | -9.80 Mn |
| Dec 31, 2022 | -17.95 Mn |
| Sep 30, 2022 | -14.43 Mn |
| Jun 30, 2022 | -29.02 Mn |
| Mar 31, 2022 | -26.00 Mn |
| Dec 31, 2021 | -27.92 Mn |
| Sep 30, 2021 | -4.43 Mn |
| Jun 30, 2021 | -35.52 Mn |